Results 91 to 100 of about 32,279 (194)

FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate

open access: yesHistopathology, Volume 89, Issue 2, Page 240-250, August 2026.
FOXA1 is a highly sensitive diagnostic marker for prostate cancer. Besides prostatic adenocarcinoma, it is also expressed in 57%–80% of metastatic or primary prostatic small cell carcinomas, which lose traditional prostatic markers including NKX3.1. Although it is less specific than NKX3.1, it can serve as a valuable adjunct for confirming prostatic ...
Jianping Zhao   +11 more
wiley   +1 more source

Medullary Thyroid Carcinoma with Micronodular Lung Metastases: A Case Report with an Emphasis on the Imaging Findings

open access: yesCase Reports in Medicine, 2010
Medullary thyroid carcinoma is a rare malignancy that arises from calcitonin-producing C-cells and frequently metastasizes to lymph nodes in the neck. Distant metastases may involve bone, lung, and liver.
Nina Ventura   +10 more
doaj   +1 more source

A Prognostic Risk Model Based on Immune Genes in Thyroid Cancer and Its Correlation With Tumor‐Associated Immune Cell Infiltration Abundance

open access: yesCancer Medicine, Volume 15, Issue 7, July 2026.
ABSTRACT Objective To investigate a prognostic risk model for thyroid cancer based on immune genes and its link to immune cell infiltration in tumors. Method This was a retrospective study of 117 thyroid cancer patients treated at our hospital from May 2021 to December 2023.
Yufan Zhang   +3 more
wiley   +1 more source

Multiple Oral and Eyelid Nodules in a Pediatric Patient

open access: yes
Oral Diseases, EarlyView.
Caique Mariano Pedroso   +10 more
wiley   +1 more source

Association Between Allergy, Asthma, and Cancer: The Japan Public Health Center‐Based Prospective Study

open access: yesCancer Medicine, Volume 15, Issue 7, July 2026.
ABSTRACT Several epidemiological studies have explored the potential associations between allergy, asthma, and cancer incidence, but the findings remain inconclusive. This study investigates the association between a history of allergy, asthma, and cancer risk in a Japanese population.
Mayo Hirabayashi   +6 more
wiley   +1 more source

What Is Your Diagnosis? Superficial Cervical Lymph Node Cytology

open access: yes
Veterinary Clinical Pathology, EarlyView.
Vinicius N. Hirata   +4 more
wiley   +1 more source

Breast Cancer Presentation, Treatment Patterns, and Progression‐Free Survival at a Tertiary Oncology Centre in Bangladesh: A Retrospective Study

open access: yesCancer Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background Breast cancer remains a major cause of cancer‐related morbidity among women worldwide, with persistent disparities in diagnosis, treatment access, and outcomes across low‐ and middle‐income settings. Institution‐based real‐world data are limited in Bangladesh.
Qamruzzaman Chowdhury   +8 more
wiley   +1 more source

A genome-wide association study yields five novel thyroid cancer risk loci

open access: yesNature Communications, 2017
Non-medullary thyroid cancers include papillary and follicular subtypes, and are the most common type of thyroid cancer. Here, the authors extend previous work by performing a large genome-wide association study and find five novel loci associated with ...
Julius Gudmundsson   +39 more
doaj   +1 more source

Oviductus Ranae as a Functional Food for Ovary Protection: Ameliorating Premature Ovarian Failure and Modulating PI3K/Akt and Apoptosis Pathways in Rats

open access: yesFood Science &Nutrition, Volume 14, Issue 7, July 2026.
Schematic illustration of the experimental design for evaluating the protective effects of Oviductus Ranae (OR) against cyclophosphamide (CTX)‐induced premature ovarian failure (POF) in rats. Female Wistar rats were intraperitoneally injected with CTX (100 mg/kg on Day 0, followed by 10 mg/kg daily) for 14–16 days to establish the POF model.
Hongyu Zhao   +6 more
wiley   +1 more source

Accelerating Pediatric Oncology Drug Development: Advances in Clinical Pharmacology, Trial Design, Non‐Clinical Evidence, and Regulatory Science

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 7, July 2026.
Abstract Pediatric oncology drug development remains uniquely challenging due to the rarity and biological heterogeneity of childhood cancers, ethical considerations in trial conduct, and the limited feasibility of large, randomized studies. Despite these barriers, recent years have seen a notable acceleration in the approval of oncology therapies for ...
Ya‐Feng Wen   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy